Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)
Completed · Phase 1/Phase 2
Conditions studied: Glomerulonephritis, Membranous, antiPLA2R Positive
In brief
This is an open-label, multicentre study to characterize the safety and efficacy of the human anti-CD38 antibody MOR202 in adult subjects with in Anti-PLA2R Antibody Positive Membranous Nephropathy (newly diagnosed/relapsed/refractory)
Key facts
- Study ID
- NCT04145440
- Run by
- HI-Bio, A Biogen Company
- People needed
- 31
- Starts
- 2019-10-15
- Expected to finish
- 2022-08-02
- Last updated by the study team
- 2025-02-24
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- North America Research Institute — Azusa, California, United States
- UCSF Medical Center — San Francisco, California, United States
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center — Torrance, California, United States
- University of Miami Division of Nephrology & Hypertension — Miami, Florida, United States
- GA Nephrology Associates — Lawrenceville, Georgia, United States
- Northwest Louisiana Nephrology Research — Shreveport, Louisiana, United States
- Kidney Care and Transplant Services of New England, PC — Springfield, Massachusetts, United States
- Mayo Clinic — Rochester, Minnesota, United States
- The Ohio State University Wexner Medical Center — Columbus, Ohio, United States
- MedResearch, Inc — El Paso, Texas, United States
- Texas Research Institute — Fort Worth, Texas, United States
- St. George Hospital — Sydney, New South Wales, Australia
- Royal Melbourne Hospital — Melbourne, Victoria, Australia
- Western Health — Melbourne, Australia
- O.L.V. Ziekenhuis — Aalst, Belgium
- C.H.U. Brugmann - Site Victor Horta — Brussels, Belgium
- Universitair Ziekenhuis Brussels — Brussels, Belgium
- Cliniques Universitaires Saint-Luc — Brussels, Belgium
- UZ Leuven — Leuven, Belgium
- CHU de Liège — Liège, Belgium
- Groupe Hospitalier Pellegrin - Hôpital Pellegrin — Bordeaux, France
- CHU de Grenoble - Hôpital Albert Michallon — Grenoble, France
- Hopital Claude Huriez -CHU Lille — Lille, France
- Hopital Tenon Service de nephrologie — Paris, France
- CHU Saint Etienne - Hôpital Nord — Saint-Priest-en-Jarez, France
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.